263 related articles for article (PubMed ID: 15503395)
1. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture.
Ziolkowski P; Osiecka BJ; Oremek G; Siewinski M; Symonowicz K; Saleh Y; Bronowicz A
J Exp Ther Oncol; 2004 Jul; 4(2):121-9. PubMed ID: 15503395
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
3. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia.
Harth Y; Hirshowitz B; Kaplan B
Dermatol Surg; 1998 Jul; 24(7):723-6. PubMed ID: 9693665
[TBL] [Abstract][Full Text] [Related]
4. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
Casas A; Fukuda H; Di Venosa G; Batlle AM
Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330
[TBL] [Abstract][Full Text] [Related]
5. Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.
Marrero A; Becker T; Sunar U; Morgan J; Bellnier D
Photochem Photobiol; 2011; 87(4):910-9. PubMed ID: 21575001
[TBL] [Abstract][Full Text] [Related]
6. The effect of folic acid on porphyrin synthesis in tumors and normal skin of mice treated with 5-aminolevulinic acid or methyl 5-aminolevulinate.
Ma L; Steindal AE; Juzeniene A; Iani V; Moan J
Photochem Photobiol Sci; 2006 Aug; 5(8):755-9. PubMed ID: 16886091
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
J Dermatol Sci; 2012 Jun; 66(3):221-4. PubMed ID: 22464765
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
9. Treating cutaneous squamous cell carcinoma using 5-aminolevulinic acid polylactic-co-glycolic acid nanoparticle-mediated photodynamic therapy in a mouse model.
Wang X; Shi L; Tu Q; Wang H; Zhang H; Wang P; Zhang L; Huang Z; Zhao F; Luan H; Wang X
Int J Nanomedicine; 2015; 10():347-55. PubMed ID: 25609949
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma.
Ahn JC; Biswas R; Mondal A; Lee YK; Chung PS
Gen Physiol Biophys; 2014; 33(1):53-62. PubMed ID: 23846261
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 5-aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes in human colon cancer cells.
Hatakeyama T; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Inoue K; Nakajima M; Otsuji E
Oncol Rep; 2013 Mar; 29(3):911-6. PubMed ID: 23291627
[TBL] [Abstract][Full Text] [Related]
12. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment of plantar warts with azone enhances the effect of 5-aminolevulinic acid photodynamic therapy.
Ziolkowski P; Osiecka BJ; Siewinski M; Bronowicz A; Ziolkowska J; Gerber-Leszczyszyn H
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):403-9. PubMed ID: 16566731
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice.
Wang H; Li J; Lv T; Tu Q; Huang Z; Wang X
Exp Dermatol; 2013 May; 22(5):362-3. PubMed ID: 23614746
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MAPK signaling pathways enhances cell death induced by 5-Aminolevulinic acid-photodynamic therapy in skin squamous carcinoma cells.
Ge X; Liu J; Shi Z; Jing L; Yu N; Zhang X; Jiao Y; Wang Y; Li PA
Eur J Dermatol; 2016 Apr; 26(2):164-72. PubMed ID: 27032574
[TBL] [Abstract][Full Text] [Related]
16. Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease.
Rodriguez L; Vallecorsa P; Battah S; Di Venosa G; Calvo G; Mamone L; Sáenz D; Gonzalez MC; Batlle A; MacRobert AJ; Casas A
Photochem Photobiol Sci; 2015 Sep; 14(9):1617-27. PubMed ID: 26066768
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
Tahmasebi H; Khoshgard K; Sazgarnia A; Mostafaie A; Eivazi MT
Photodiagnosis Photodyn Ther; 2016 Mar; 13():297-302. PubMed ID: 26321747
[TBL] [Abstract][Full Text] [Related]
18. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
19. Assessment of in vivo experiments: The newly synthesized porphyrin with proper light source enhanced effectiveness of PDT comparing to 5-ALA-mediated PDT.
Jurczyszyn K; Woźniak M; Symonowicz K; Sprutta N; Latos-Grażyński L; Ziółkowski P; Ivonyak Y; Tuchowski P; Trzeciakowski W
Photodiagnosis Photodyn Ther; 2017 Jun; 18():179-184. PubMed ID: 28254552
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid photodynamic therapy of transplantable colon adenocarcinoma in BALB/c mice.
Ziółkowski P; Symonowicz K; Osiecka BJ; Rabczyński J
Arch Immunol Ther Exp (Warsz); 1998; 46(5):301-4. PubMed ID: 9832069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
